About Onco'Zine, ADC Review | Journal of Antibody-drug Conjugates and The Onco'Zine Brief
Delivering Quality Information to Oncologists, Hematologists, Oncology Nurses, Physicians, Academic and Industry Researchers, Allied Health Professionals, and Patients and their Family and Friends
Onco’Zine (the journal), The Onco'Zine Brief (the radio show/podcast) and ADC Review | Journal of Antibody-drug Conjugates have been created to inform and support physicians and healthcare professionals treating cancer patients. The journals and radio show/podcast are trusted sources of news coverage focusing on current (clinical) research and development in oncology and hematology.
We cover oncology and hematology news
We cover news, findings, and announcements we think will directly affect the practice of healthcare throughout the United States. Independent, and deeply rooted in both Oncology/Hematology and Journalism, our reporters are impartial and seasoned writers and story tellers who write with journalistic integrity and cover the most important topics and subjects from the world of Oncology and Hematology.
Driven to build the absolute best destination for anyone interested in accurate oncology focused news and information, each one of our journalists, writers and editors are is experts in their respective area of expertise. And... our editors are experts who are meticulously fact-checking every article we publish.
Meeting and conference coverage
Onco'Zine, ADC Review | Journal of Antibody-drug Conjugates and The Onco'Zine Brief rely heavily on in-person specialized coverage of scientific meetings and conferences. Correspondents throughout the United States, Canada and Europe supply first-hand reports and interviews with researchers, clinicians, and industry representatives and government figures whose work and actions are changing the practice of oncology and hematology.
Each year, our correspondents attend roughly 20 - 25 oncology-oncologt-focused meetings and conferences in the United states and around the world to bring you the most relevant oncology and hematology news and information. On average, we send between 2 and 3 seasoned writers to each of these meetings/conference. In addition, we work with highly experienced freelance writers and journalists to ensure that our news coverages unbiased and our analysis is complete and comprehensive.
Guest Essays, OpEds and Editorials
As a peer-to-peer/professional science & medicine based network we welcome contributions from healthcare professionals. We publish OpEds, Editorials, Guest Essays and other contributed articles from our readers as well as Key Opinion Leaders (KOLs) and members from our Editorial Advisory Board.
National Cancer Institute
Onco'Zine is a National Cancer Institute content distribution partner. As a content distribution partner, this publication includes regularly updated NCI-produced content and information. Where applicable, the date of the last update is included on pages containing medical and/or health related information and pages containing general information.
Information for HCPs
The information contained on this site is generally technical or scientific in nature and intended for Healthcare Professionals. If you are a patient and have questions about a particular disease or topic, please visit the information marked 'patient information' and ask your doctor for additional information how this information may apply to you. Furthermore, where applicable for general use, information provided on this site is meant to complement and not replace any advice or information from a Healthcare Professional.
Our radio show/podcast
We produce a weekly radio show, The Onco'Zine Brief with host Peter Hofland. The (broadcast) radio show/podcast is a forum in which researchers, healthcare professionals, representatives from industry, regulators, patient advocates and patients are invited as guests to talk about important oncology/hematology focused topics. The program also covers round tables and news and interviews from oncology/hematology meetings and conferences.
An unbiased editorial environtment
Onco'Zine - The International Oncology Network, ADC Review | Journal of Antibody-drug Conjugates and The Onco'Zine Brief offers an unbiased editorial environment and does not included claims relating to the benefit or performance of a specific medical treatment, commercial product or service.
Peter Hofland | Publisher and Executive Editor (USA)
Danielle Garcia | Co-Executive Publisher /Cirrespondent (Europe)
Eric Rosenthal | Editor-at-Large
Sonya Saldana | Consultant/Medical Education
Abigail Adair | Consultant
Broadcast/Podcast Production Team
Peter Hofland | Executive Producer and Host
Sonia Portillo | Co-Host
Shelly Reynolds | Co-Host
Danielle Garcia | Co-Executive Producer
Ginni Saraswati | Producer
Kourtney Balsan | Associate Producer
Paul Schmidt | Reporter
Bryant Reyes | Reporter
Ashley Tough | Senior Editor
Eric Rosenthal | Editor-at-Large
David Caylor | Voice Talent
Johann Ilgenfritz | UK Health Radio
Our Supporting staff
Our work and the work of our writers journalists, editors, reporters and correspondents would not be possible without our our team of project managers, assignment editors, publication planners, designers, marketers, web engineers and programmers, data scientists, and many more experts.
Funding: Advertisement and Sponsoring Options
Onco'Zine, The International Oncology Network is published by Sunvalley Communication, LLC. The publication is, in part, funded by advertisement and sponsorships. Contact our sales team for more information about advertising and sponsorship.
Join Onco'Zine - Invitation to Register
We invite healthcare professionals (HCPs) to become registered members of Onco'Zine - The International Cancer Network. Our initiative aspires to engage healthcare providers, share news and developments and strengthen the international oncology and hematology community through an exchange of ideas and opinions among peers. Members will gain access to news, information and educational materials as they become available. These materials are intended to enhance understanding and knowledge base of the community. If you're a healthcare professional (HCP), please take a moment to register.
Sign up for our Newsletter
To sign up for The Onco'Zine Newsletter (open for residents of the United States only), text the word CANCER to 66866.
Onco'Zine and Social Media
We are proud to be active and responsive on all major social networking platforms. Whether you're looking for news, announcements, or information, you'll find Onco'Zine - The International Oncology Network, ADC Review | Journal of Antibody-drug Conjugates and The Onco'Zine Brief wherever you go, including Facebook, Twitter, LinkedIn and other social media accounts.
If you have a question or comments about our editorial content, please let us know by contacting our support team at:
Sunvalley Communication, LLC
Editorial Management Onco’Zine
4960 South Gilbert Rd, Suite 1-286,
Chandler, Arizona 85249
The information in this journal is for North American and European Health professionals and is intended to be an educational resource only. It is not intended or deemed to be a guide regarding appropriate diagnosis or treatment. This information in this journal is not a substitute for the decisions made by a licensed physician. A treating physician is solely responsible for making evidence-based decisions relating to appropriate patient care, including, but not limited to diagnosis, surgery, medication, dose, scheduling and supporting care. Before prescribing any medication, review the complete prescribing information.
Editorial Advisory Board
Onco'Zine - The International Oncology Network, ADC Review | Journal of Antibody-drug Conjugates and The Onco'Zine Brief are guided by an Executive Editor and an independent Editorial Advisory Board. To Join the Editorial Advisory Board and represent your community of oncologists, hematologist, physicians, oncology-nurses, practitioners, academic specialists or industry leaders with cross-disciplinary expertise. Click Here for more information.
The Onco'Zine Brief
The Onco'Zine Brief is an interview and discussion program covering a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The program is a sponsor-supported broadcast/podcast for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends.
How to join as a guest
Being a guest in The Onco'Zine Brief helps brand you as an expert, increase your awareness, establishes you as a thought leader, educates people and promotes your business. It is relatively easy to do. As a guest you’ll be discussing your area of expertise. It is not difficult to set up. If you're interested, contact the editorial team. Interviews can be in person or remotely.
Sponsorship of Conference Coverage of important medical society and industry meetings offers broad brand exposure across multiple channels including exclusive placement on our conference/meeting specific landing pages, newsletters, along with podcasts and video interviews and specialty online channels during the select conference.
Download the 2023/2024 Media Kit for an overview of an unique blend of advertisement and sponsorship solutions designed to develop a strategic and customized targeted media campaign.
Partner with our team! We'll help you with analyzing your objectives and goals and then collaborate with your team in developing a successful advertising and sponsorship campaign. When you download our Media Kit we will keep you informed about all our integrated solutions.
ADC Review | Journal of Antibody-drug Conjugates (ISSN 2327-0152), launched in 2013, is designed to serve the needs of a diverse community of individuals including academia, life sciences, Pharma, (basic, translational and clinical) research, clinicians/physicians, along with regulatory affairs, government authorities and representatives from payers, and policy makers.
The Oncology Directory provides a comprehensive, member-driven resource to search, review, compare and connect with all of the key stakeholders involved in the development of novel cancer agents, cancer diagnostics and treatment of patients with cancer.
The ADC Directory provides a seamless exchange of information between businesses and professionals focused on the research, development and manufacture of antibody-drug conjugates. Members have the opportunity to share reviews, articles, videos, events, products, career opportunities and more.